Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-018280
Filing Date
2022-01-26
Accepted
2022-01-26 16:05:58
Documents
10
Period of Report
2022-03-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d298856ddef14a.htm DEF 14A 928563
2 GRAPHIC g298856g01015.jpg GRAPHIC 252330
3 GRAPHIC g298856g01r22.jpg GRAPHIC 156711
4 GRAPHIC g298856g02w11.jpg GRAPHIC 224304
5 GRAPHIC g298856g03z11.jpg GRAPHIC 86131
6 GRAPHIC g298856g08m78.jpg GRAPHIC 50524
7 GRAPHIC g298856g20a36.jpg GRAPHIC 36491
8 GRAPHIC g298856g27e04.jpg GRAPHIC 54665
9 GRAPHIC g298856g57a00.jpg GRAPHIC 143345
10 GRAPHIC g298856g70d20.jpg GRAPHIC 68095
  Complete submission text file 0001193125-22-018280.txt   2408304
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 22557900
SIC: 2834 Pharmaceutical Preparations